PREZCOBIX Approved By FDA
Today the FDA approved Janssen Therapeutics combination HIV antiretroviral, PREZCOBIX which is a combination of darunavir 800mg and cobicistat 150mg.
PREZCOBIX is indicated for the treatment of HIV-1 in combination with
Michelle
